GH

Zacks highlights two medical stocks with positive Earnings Surprise Prediction (ESP) figures that could beat upcoming earnings expectations. Danaher (DHR) has a +0.30% ESP with a #2 Buy rating ahead of October 21 earnings, while Guardant Health (GH) has a +13.19% ESP with a #2 Buy rating before November 5 earnings. Both stocks show potential for positive earnings surprises based on recent analyst revisions.

Natera announced a strategic collaboration with TransCode Therapeutics to use its Signatera MRD test for identifying eligible patients in a Phase 2a trial evaluating TTX-MC138, an investigational therapy targeting miR-10b in colorectal cancer patients. The partnership aims to accelerate patient enrollment by detecting residual cancer in patients with no detectable disease on imaging, addressing an unmet medical need in early cancer recurrence intervention.

FXH is a passively managed healthcare ETF launched in 2007 with $1.13 billion in assets. It tracks the StrataQuant Health Care Index with a 0.61% expense ratio and 0.56% dividend yield.

The fund has gained 16.87% year-to-date and 20.02% over the past year, with a medium risk profile (beta 0.72). It holds 74 healthcare companies with top holdings including Natera, Guardant Health, and Universal Health Services. FXH received a Zacks ETF Rank of 3 (Hold).